Stay updated on PD-1/CD137 Blockade with Cell Therapy in Melanoma Clinical Trial

Sign up to get notified when there's something new on the PD-1/CD137 Blockade with Cell Therapy in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PD-1/CD137 Blockade with Cell Therapy in Melanoma Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Major update: announces a version upgrade to v3.2.0 and publicly states funding-related operational notices, including that transactions may not be processed until appropriations are enacted.
    Difference
    3%
    Check dated 2025-10-06T04:13:43.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The page update primarily introduces a new version label (v3.1.0) and removes an old term (Melanoma, Cutaneous Malignant) tied to v3.0.2; no substantive core content, pricing, or time-sensitive data appears to be added.
    Difference
    0.3%
    Check dated 2025-09-28T23:29:57.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    Added a new 'Helpful Links' section linking to Moffitt Cancer Center and Clinical Trials site; no deletions.
    Difference
    0.7%
    Check dated 2025-09-21T19:41:49.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    Added Revision: v3.0.2 and removed older references (v3.0.1, Back to Top, and the Helpful Links section). This is a minor housekeeping update with no impact on core content.
    Difference
    0.9%
    Check dated 2025-09-14T09:48:04.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.
    Difference
    0.2%
    Check dated 2025-09-07T07:41:15.000Z thumbnail image
  7. Check
    48 days ago
    Change Detected
    Summary
    The web page has been updated to include new drug information related to skin cancer treatments, specifically mentioning drugs like Nivolumab and Ciltacabtagene Autoleucel, while removing several previous references to immunosuppressive and antineoplastic agents.
    Difference
    6%
    Check dated 2025-08-31T00:56:50.000Z thumbnail image

Stay in the know with updates to PD-1/CD137 Blockade with Cell Therapy in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PD-1/CD137 Blockade with Cell Therapy in Melanoma Clinical Trial page.